Announced Mon, 5 Oct, 2026 · 19:04 IST
Whole-time Director Ravindra Salaskar resigns, continues as CFO
SAROJA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction
Awaiting price reaction for this filing.
AI summary
Mr. Ravindra Shivaji Salaskar resigned as Whole-time Director of Saroja Pharma Industries India effective 5 October 2026, citing personal reasons and a need to realign professional commitments. Importantly, he clarified that he will continue to serve as the Chief Financial Officer (CFO) of the company, so finance leadership remains unchanged. The filing is limited to his exit from the board, with no successor named yet.
Likely market impact
Board-level exit with CFO continuity, so finance oversight is preserved. Investors should watch for a successor appointment announcement.